Clincosm LogoSign in Get a demo

Astrocytoma

Showing 1 - 25 of 62
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diffuse Astrocytoma, Anaplastic Astrocytoma, Astrocytoma Trial in Worldwide (dabrafenib, trametinib)

Recruiting
  • Diffuse Astrocytoma
  • +22 more
  • Phoenix, Arizona
  • +26 more
Jan 27, 2023

Astrocytoma, Oligodendroglioma, Adult, Glioma, Malignant Trial in Saint Louis (temporally-modulated pulsed radiotherapy (TMPRT))

Recruiting
  • Astrocytoma
  • +2 more
  • temporally-modulated pulsed radiotherapy (TMPRT)
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 19, 2023

Malignant Glioma of Brain, Astrocytoma, Malignant Astrocytoma Trial in Detroit (Ad5-yCD/mutTKSR39rep-ADP adenovirus and

Recruiting
  • Malignant Glioma of Brain
  • +8 more
  • Ad5-yCD/mutTKSR39rep-ADP adenovirus and fractionated stereotactic radiosurgery (fSRS)
  • Detroit, Michigan
    Henry Ford Health System
Jan 9, 2023

Glioblastoma, Astrocytoma, Venous Thromboembolism Trial (Apixaban)

Not yet recruiting
  • Glioblastoma
  • +2 more
  • (no location specified)
Jan 4, 2023

Astrocytoma, Glioblastoma Trial in Spain, United States (CC-90010)

Active, not recruiting
  • Astrocytoma
  • Glioblastoma
  • Jacksonville, Florida
  • +8 more
Dec 14, 2022

Adult Diffuse Glioma Based on Deep Learning

Recruiting
  • Astrocytoma
  • +2 more
  • multi-parametric magnetic resonance imaging scan
  • Pathology examination
  • Nanjing, Jiangsu, China
    Department of Radiology, the Affiliated Drum Tower Hospital of N
Nov 21, 2022

Adenocarcinoma, Adenocystic Carcinoma, Anal Cancer Trial in Idaho Falls (diagnostic test, drug, other)

Recruiting
  • Adenocarcinoma
  • +75 more
  • Biomarker Testing (L)
  • +2 more
  • Idaho Falls, Idaho
  • +1 more
Oct 18, 2022

Glioblastoma, Astrocytoma, Oligodendroglioma Trial (OKN-007)

Withdrawn
  • Glioblastoma
  • +2 more
  • (no location specified)
Oct 5, 2022

High-grade Glioma, Oligodendroglioma, Astrocytoma Trial (Low-dose OKN-007, BID, Low-dose OKN-007, TID, Mid-dose OKN-007, TID)

Not yet recruiting
  • High-grade Glioma
  • +3 more
  • Low-dose OKN-007, BID
  • +3 more
  • (no location specified)
Sep 26, 2022

Glioblastomas, Sarcoma, Astrocytoma Trial run by the NCI (Enhanced Mindfulness Intervention, Psychoeducation)

Completed
  • Glioblastomas
  • +4 more
  • Enhanced Mindfulness Intervention
  • Psychoeducation
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Sep 14, 2022

Astrocytoma, Glioblastoma, Glioblastoma, IDH-Wildtype Trial in Chicago (drug, other, radiation)

Recruiting
  • Astrocytoma
  • +4 more
  • Mycophenolate Mofetil
  • +3 more
  • Chicago, Illinois
    Northwestern University
Aug 22, 2022

Astrocytoma, Glioblastoma, Oligodendroglioma Trial in Atlanta (Craniotomy, Quantitative Oblique Back-Illumination Microscopy)

Not yet recruiting
  • Astrocytoma
  • +2 more
  • Craniotomy
  • Quantitative Oblique Back-Illumination Microscopy
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Aug 22, 2022

Astrocytoma Trial (Vorasidenib, Pembrolizumab)

Not yet recruiting
  • Astrocytoma
  • (no location specified)
Aug 1, 2022

Glioma, IDH Mutation, Astrocytoma Trial in Philadelphia (Retifanlimab, All-trans retinoic acid)

Not yet recruiting
  • Glioma
  • +3 more
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Jul 22, 2022

Glioma, Pilocytic Astrocytoma, Anaplastic Astrocytoma Trial in Saint Louis (MRI-guided laser ablation, Doxorubicin, Etoposide)

Recruiting
  • Glioma
  • +8 more
  • MRI-guided laser ablation
  • +4 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jun 22, 2022

Astrocytoma, Brain Cancer, Brain Metastases Trial in Kogarah, Liverpool (QBS10072S)

Recruiting
  • Astrocytoma
  • +22 more
  • Kogarah, New South Wales, Australia
  • +1 more
Apr 18, 2022

Astrocytoma, Ependymoma, Ganglioglioma Trial in Maastricht, Delft, Groningen (ProTRAIT)

Recruiting
  • Astrocytoma
  • +11 more
  • ProTRAIT
  • Maastricht, Limburg, Netherlands
  • +2 more
Apr 12, 2022

Glioblastoma, Glioblastoma Multiforme, Glioma Trial in Los Angeles (Dendritic cell vaccination, in addition to standard

Completed
  • Glioblastoma
  • +4 more
  • Dendritic cell vaccination, in addition to standard temozolomide chemotherapy and involved field radiation therapy
  • Dendritic cell vaccination, with optional bevacizumab treatment for patients previously treated with bevacizumab
  • Los Angeles, California
    Cedars-Sinai Medical Center
Nov 18, 2021

Qualitative, Qualitative, and Functional Studies Over First Year

Completed
  • Astrocytoma
  • +2 more
  • Hepatitis A Vaccine
  • +3 more
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Oct 28, 2021

Brain Tumor, Low Grade Glioma, Astrocytoma Trial in Boston (Proton radiotherapy)

Active, not recruiting
  • Brain Tumor
  • +4 more
  • Proton radiotherapy
  • Boston, Massachusetts
  • +1 more
Sep 30, 2021

Brain Tumor, Astrocytoma, Astroglioma Trial run by the NCI (Zotiraciclib (TG02), Temozolomide (TMZ))

Completed
Has Results
  • Brain Tumor
  • +4 more
  • Zotiraciclib (TG02)
  • Temozolomide (TMZ)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Sep 3, 2021

Educating Brain Tumor Patients Using Patient-specific

Recruiting
  • Brain Tumor
  • +7 more
  • Three-dimensional printed model
  • Nijmegen, Gelderland, Netherlands
    Radboud University Medical Center
Jul 10, 2021

MicroRNA-10b in Patients With Gliomas

Recruiting
  • Astrocytoma
  • +8 more
    • Boston, Massachusetts
    • +3 more
    May 30, 2021

    Grade II Glioma, Grade III Glioma, Grade IV Glioma Trial in Boston (Microdevice)

    Recruiting
    • Grade II Glioma
    • +7 more
    • Microdevice
    • Boston, Massachusetts
      Brigham and Women's Hospital
    Feb 22, 2021

    Oligoastrocytoma, Astrocytoma, Oligodendroglioma Trial (device, procedure, other)

    Completed
    • Oligoastrocytoma
    • +2 more
    • fMRI
    • +2 more
    • (no location specified)
    Sep 1, 2020